Home  |  Contact

Cellosaurus A2780-DX1 (CVCL_4T95)

Cell line name A2780-DX1
Accession CVCL_4T95
Resource Identification Initiative To cite this cell line use: A2780-DX1 (RRID:CVCL_4T95)
Comments Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Disease Ovarian endometrioid adenocarcinoma (NCIt: C7979)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0134 (A2780)
CVCL_4T96 (A2780-DX2)
Sex of cell Female
Age at sampling Age unspecified
Category Cancer cell line

PubMed=2598402; DOI=10.1007/BF00692343
Alaoui-Jamali M.A., Yin M.-B., Mazzoni A., Bankusli I., Rustum Y.M.
Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933.
Cancer Chemother. Pharmacol. 25:77-83(1989)

PubMed=2243668; DOI=10.1159/000226878
Mazzoni A., Trave F., Russo P., Nicolin A., Rustum Y.M.
Generation and characterization of a low-degree drug-resistant human tumor cell line.
Oncology 47:488-494(1990)

Other Wikidata; Q54606565